Juliane Bubeck Wardenburg

Dr. Juliane Bubeck Wardenburg


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2013 in Toxins
Verified
Journal Article
Open access
PDF file
BBBryan J. Berube
Bryan J. Berube
JWJuliane Bubeck Wardenburg
Juliane Bubeck Wardenburg
Staphylococcus aureus secretes a number of host-injurious toxins, among the most prominent of which is the small β-barrel pore-forming toxin α-hemolysin. Initially named based on its properties as a red blood cell lytic toxin, early studies suggested a far greater complexity of α-hemolysin action as nucleated cells also exhibited distinct responses to intoxication. The hemolysin, most aptly referred to as α-toxin based on its broad range of cellular specificity, has long been recognized as an important cause of injury in the context of both skin necrosis and lethal infection. The recent identification of ADAM10 as a cellular receptor for α-toxin has provided keen insight on the biology of toxin action during disease pathogenesis, demonstrating the molecular mechanisms by which the toxin causes tissue barrier disruption at host interfaces lined by epithelial or endothelial cells. This review highlights both the historical studies that laid the groundwork for nearly a century of research on α-toxin and key findings on the structural and functional biology of the toxin, in addition to discussing emerging observations that have significantly expanded our understanding of this toxin in S. aureus disease. The identification of ADAM10 as a proteinaceous receptor for the toxin not only provides a greater appreciation of truths uncovered by many historic studies, but now affords the opportunity to more extensively probe and understand the role of α-toxin in modulation of the complex interaction of S. aureus with its human host.

12 July 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
GWGeorgia A. Wilke
Georgia A. Wilke
JWJuliane Bubeck Wardenburg
Juliane Bubeck Wardenburg
Staphylococcus aureus α-hemolysin (Hla), a potent cytotoxin, plays an important role in the pathogenesis of staphylococcal diseases, including those caused by methicillin-resistant epidemic strains. Hla is secreted as a water-soluble monomer that undergoes a series of conformational changes to generate a heptameric, β-barrel structure in host membranes. Structural maturation of Hla depends on its interaction with a previously unknown proteinaceous receptor in the context of the cell membrane. It is reported here that a disintegrin and metalloprotease 10 (ADAM10) interacts with Hla and is required to initiate the sequence of events whereby the toxin is transformed into a cytolytic pore. Hla binding to the eukaryotic cell requires ADAM10 expression. Further, ADAM10 is required for Hla-mediated cytotoxicity, most notably when the toxin is present at low concentrations. These data thus implicate ADAM10 as the probable high-affinity toxin receptor. Upon Hla binding, ADAM10 relocalizes to caveolin 1-enriched lipid rafts that serve as a platform for the clustering of signaling molecules. It is demonstrated that the Hla–ADAM10 complex initiates intracellular signaling events that culminate in the disruption of focal adhesions.

1 December 2017 in Seminars in Cell & Developmental Biology
Verified
Journal Article
Closed access
ESE. Sachiko Seilie
E. Sachiko Seilie
JWJuliane Bubeck Wardenburg
Juliane Bubeck Wardenburg

18 July 2016 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
AHAaron L Hecht
Aaron L Hecht
BCBenjamin W Casterline
Benjamin W Casterline
ZEZachary M Earley
Zachary M Earley
YGYoung Ah Goo
Young Ah Goo
DGDavid R Goodlett
David R Goodlett
JWJuliane Bubeck Wardenburg
Juliane Bubeck Wardenburg

2 April 2012 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MPMichael E. Powers
Michael E. Powers
HKHwan Keun Kim
Hwan Keun Kim
YWYang Wang
Yang Wang
JWJuliane Bubeck Wardenburg
Juliane Bubeck Wardenburg
Staphylococcus aureus is a leading cause of bacteremia and sepsis. The interaction of S. aureus with the endothelium is central to bloodstream infection pathophysiology yet remains ill-understood. We show herein that staphylococcal α-hemolysin, a pore-forming cytotoxin, is required for full virulence in a murine sepsis model. The α-hemolysin binding to its receptor A-disintegrin and metalloprotease 10 (ADAM10) upregulates the receptor’s metalloprotease activity on endothelial cells, causing vascular endothelial–cadherin cleavage and concomitant loss of endothelial barrier function. These cellular injuries and sepsis severity can be mitigated by ADAM10 inhibition. This study therefore provides mechanistic insight into toxin-mediated endothelial injury and suggests new therapeutic approaches for staphylococcal sepsis.

1 July 2009 in Infection and Immunity
Verified
Journal Article
Closed access
BRBrook E. Ragle
Brook E. Ragle
JWJuliane Bubeck Wardenburg
Juliane Bubeck Wardenburg
Staphylococcus aureuspneumonia is one of the most common invasive diseases caused by this human pathogen.S. aureusalpha-hemolysin, a pore-forming cytotoxin, is an essential virulence factor in the pathogenesis of pneumonia. Vaccine-based targeting of this toxin provides protection against lethal staphylococcal pneumonia in a murine model system, suggesting that a monoclonal antibody-based therapy may likewise prove to be efficacious for prevention and treatment of this disease. We report the generation of two distinct anti-alpha-hemolysin monoclonal antibodies that antagonize toxin activity, preventing human lung cell injury in vitro and protecting experimental animals against lethalS. aureuspneumonia. Each of these two monoclonal antibodies recognized an epitope within the first 50 amino acid residues of the mature toxin and blocked the formation of a stable alpha-hemolysin oligomer on the target cell surface. Active immunization with the first 50 amino acids of the toxin also conferred protection againstS. aureuspneumonia. Together, these data reveal passive and active immunization strategies for prevention or therapy of staphylococcal pneumonia and highlight the potential role that a critical epitope may play in defining human susceptibility to this deadly disease.